Bilirubin

Europe PMC · fetched just now · sorted by publication date

1. 1
   Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-κB, and SLC22A7 in bile acid metabolism.

   Qiu S, Qiang S, Wang Z, Yang L, Guo S, Zeng J, Cai Y, Lai Z, Xie D, Che L, Zhang A. · 2026-07-19

   unreviewed
2. 2
   Longitudinal symptom dynamics in postoperative patients with liver cancer: A cross-lagged panel network analysis.

   Zhang S, Cai Y, Zhao M, Luo T, Zhu Y, Han J. · 2026-04-17

   open access unreviewed
3. 3
   High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study.

   Ma J, Chen H, Guo C, He G, Yang G. · 2026-06-17

   open access unreviewed
4. 4
   Successful treatment of idiopathic multicentric Castleman disease with TAFRO and kidney involvement: case report and literature review.

   Kamal AI, Doppalapudi H, Ho T, Vilayet S, Pasham V, Budisavljevic M, Achanti A. · 2026-06-17

   open access unreviewed
5. 5
   Dental pulp cell-derived conditioned culture media promotes periodontal repair through immunomodulation and bone regeneration.

   Kanazawa S, Ono S, Shinchi H, Kanno H, Ueda K, Ishimaru N, Takemoto K, Hoshi K. · 2026-06-04

   open access unreviewed
6. 6
   Dynamic changes in frailty and related factors in older patients with liver cancer: A latent transition analysis approach.

   Zhou Q, Mao H, Wang Y, Zhang X, Hu N, Li C. · 2026-05-12

   open access unreviewed
7. 7
   A body roundness index (BRI)-based predictive model for metabolic syndrome in perimenopausal and postmenopausal women-from a cross-sectional machine learning study to a longitudinal dynamic assessment.

   Xi Y, Sun Q, Han Y, Zhu P, Guo J, Zhang B, Fan J, Hong Z, Li X. · 2026-06-06

   open access unreviewed
8. 8
   Deconfounded, quantitative microbiome profiling identifies robust multiple sclerosis markers and clinical covariate associations.

   Pauwels A, Devolder L, Falony G, D'haeseleer M, Nagels G, Van Remoortel A, Derrien M, D'hooghe M, Raes J. · 2026-06-05

   open access unreviewed
9. 9
   Analytical and clinical validation of a competitive ELISA for serum indoxyl sulfate and its clinical association with chronic kidney disease risk stratification.

   Hou YC, Chuang YC, Cheng YW, Huang HY, Chen LY, Tseng TL, Lu KC. · 2026-06-02

   open access unreviewed
10. 10
    Albumin as a dynamic extracellular redox regulator: from Cys34 oxidation biomarkers to polysulfide-mediated homeostatic mechanisms and clinical applications.

    Ishima Y, Watanabe H, Ikeda-Imafuku M, Maeda H, Maruyama T, Otagiri M, Chuang VTG. · 2026-06-02

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.